Azenta Life Sciences to Participate in the 40th Annual J.P. Morgan Conference
Azenta, Inc. (Nasdaq: AZTA) will participate in the 40th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Azenta, Inc. (Nasdaq: AZTA) will participate in the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 3:45 p.m. EST. The conference will be held virtually, and the presentation can be accessed through the Azenta investor relations website. A replay will be available post-event. Recently rebranded from Brooks Automation, Azenta provides life sciences solutions and cold-chain sample management services globally. The company is headquartered in Chelmsford, MA, and operates in North America, Europe, and Asia.
Details
News Market Reaction – AZTA
The recorded move for AZTA in the trading session of this news was +0.88%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHELMSFORD, Mass., Dec. 21, 2021 /PRNewswire/ -- Azenta, Inc. (Nasdaq:AZTA) announced today that company management will participate in the 40th Annual J.P. Morgan Healthcare Conference. The conference coordinators recently determined the event will be held in a virtual environment. Azenta management will present via webcast on Wednesday, January 12, 2022 beginning at 3:45 p.m. EST which can be accessed through the Azenta investor relations website at www.investors.azenta.com/events. A replay of the webcast will be available following the event.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. As of December 1st, the company changed its name and ticker to Azenta, Inc. (Nasdaq: AZTA) from Brooks Automation, Inc, (Nasdaq: BRKS).
In addition, the company operates the Semiconductor Solutions Group business, an industry-leading provider of semiconductor manufacturing automation and collaborative robotics solutions worldwide. On September 20, 2021, the Company announced the pending sale of this business to Thomas H. Lee Partners. Due to the pending divestiture, the Company began reporting the Semiconductor Solutions Group business as discontinued operations in its fiscal year-end earnings announcement.
Azenta is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
INVESTOR CONTACTS:
Sara Silverman
Director, Investor Relations
Azenta Life Sciences
978.262.2635
sara.silverman@azenta.com
Sherry Dinsmore
Azenta Life Sciences
978.262.2400
sherry.dinsmore@azenta.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-life-sciences-to-participate-in-the-40th-annual-jp-morgan-conference-301449343.html
SOURCE Azenta
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.